Advanced Search

 

Study ID Status Title Patient Level Data
RPS10001 Completed A phase I, monocentric, randomised, double-blind, double-dummy, cross-over study to compare the pharmacokinetics and the pharmacodynamic effects of Seretide 50 mg/250 mg bid after repeat dosing, delivered by Diskus™ versus RPID in patients with moderate asthma.
RPS30001/SFCF3002 Completed A Multicentre, Randomised, Double-Blind, Double-Dummy, Parallel-Group Study to establish Equivalence of the Fluticasone propionate/Salmeterol Combination (FSC) Product (100/50µg) via either the Reservoir Powder Inhalation Device (RPID) or via the Diskus* Inhaler over 12 Weeks in Children with Asthma
RPS30002/SFCF3001 Completed A Multicentre, Randomised, Double-Blind, Double-Dummy, Parallel-Group Study to Establish Equivalence of the Salmeterol/Fluticasone propionate Combination Product (50/250µg) via either the Reservoir Powder Inhalation Device (RPID) or via the Diskus™ Inhaler over 12 Weeks in Adolescents and Adults ...
RQ12003 Completed Treatment of Parkinson’s disease subjects which are on L-dopa with adjunct treatment with ropinirole (ReQuip) in neurology outpatient department.
RRL103628 Completed An Open-Label, Parallel-Group, Repeat-Dose Study to Investigate the Effects of End Stage Renal Disease and Haemodialysis on the Pharmacokinetics of Ropinirole (Study RRL103628) Study Listed on ClinicalStudyDataRequest.com
RRL103660 Completed A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients with Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep Study Listed on ClinicalStudyDataRequest.com
RRL106721 Completed A multicenter 3:1-randomized placebo-controlled double-blind Phase IIIb study on the effects of Ropinirole on mood/(subclinical) depression in the therapy of patients with moderate to severe idiopathic RLS in Germany
RXP110908 Completed Study RXP110908, a polysomnography study of GSK1838262 (XP13512) extended release tablets versus placebo in the treatment of Restless Legs Syndrome (RLS) and associated sleep disturbance
S2090309 Completed An Evaluation of a Low Dose Nicotine Lozenge in Relief of Provoked Acute Craving
S2110367 Completed A Randomized, Open Label Study to Evaluate the Oral Tolerability of a Nicotine Prototype
S2111378 Completed A Pilot Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Strip, Nicorette ® Nicotine Lozenge and Gum
S2540345 Completed An evaluation of the 4mg nicotine mint lozenge for the relief of cognitive impairment associated with nicotine withdrawal
S2B-121 Completed Evaluation of the Anatomic Site of Absorption of Sumatriptan (GR43175).
S2B-124 Completed A Study to Evaluate the Bioequivalence of 50 and 100mg Sumatriptan Tablets.
S2B-199 Completed The evaluation of electrocardiograms following a single 100mg oral dose of GR43175C administered to healthy male volunteers.
S2B-201 Completed Evaluation of the safety and efficacy of subcutaneous GR43175C in migraine patients.
S2B203 Completed Evaluation of the effect of GR43175C on blood pressure in hypertensive migraine patients.
S2B210 Completed Efficacy of subcutaneous sumatriptan administered by the Glaxo autoinjector device- Protocol S2B210
S2B211 Completed Efficacy of subcutaneous sumatriptan administered by the Glaxo autoinjector device- Protocol S2B211.
S2B222 Completed A study to investigate the effects of subcutaneous GR43175C on the coronary vasculature in patients with existing or suspected coronary artery disease.
S2B307 Completed Repeat-dose efficacy and laboratory safety trial of subcutaneous GR43175C in migraine patients.
S2B308 Completed Evaluation of sumatriptan in the treatment of migraine pain recurrence- a pilot study.
S2B308E Completed Evaluation of sumatriptan in the treatment of migraine pain recurrence- extension.
S2B-341 Completed A double-blind, placebo-controlled, parallel group study to evaluate two dose levels (10mg and 20mg) of intranasal sumatriptan in the acute treatment of a migraine attack.
S2B-H27 Completed A study to determine whether ergotamine (0.25mg given intravenously) has any effect on the pharmacodynamics and pharmacokinetics of GR43175C in healthy subjects.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.